Display options
Cite
Galbo PM, Ciesielski MJ, Figel S, et al. Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination. Oncotarget. 2017;8(70):114722-114735doi: 10.18632/oncotarget.21773.
Galbo, P. M., Ciesielski, M. J., Figel, S., Maguire, O., Qiu, J., Wiltsie, L., Minderman, H., & Fenstermaker, R. A. (2017). Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination. Oncotarget, 8(70), 114722-114735. https://doi.org/10.18632/oncotarget.21773
Galbo, Phillip M, et al. "Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination." Oncotarget vol. 8,70 (2017): 114722-114735. doi: https://doi.org/10.18632/oncotarget.21773
Galbo PM, Ciesielski MJ, Figel S, Maguire O, Qiu J, Wiltsie L, Minderman H, Fenstermaker RA. Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination. Oncotarget. 2017 Oct 10;8(70):114722-114735. doi: 10.18632/oncotarget.21773. eCollection 2017 Dec 29. PMID: 29383115; PMCID: PMC5777727.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Oct 10;8(70):114722-114735. doi: 10.18632/oncotarget.21773. eCollection 2017 Dec 29.

Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination.

Oncotarget

Phillip M Galbo, Michael J Ciesielski, Sheila Figel, Orla Maguire, Jingxin Qiu, Laura Wiltsie, Hans Minderman, Robert A Fenstermaker

Affiliations

  1. Department of Neurosurgery, Roswell Park Cancer Institute, Buffalo, New York, 14263 USA.
  2. Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York, 14263 USA.
  3. Jacobs School of Medicine and Biomedical Sciences, State University of New York, Buffalo, New York, 14214 USA.
  4. Flow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York, 14263 USA.
  5. Pathology, Roswell Park Cancer Institute, Buffalo, New York, 14263 USA.
  6. Pediatrics, Roswell Park Cancer Institute, Buffalo, New York, 14263 USA.

PMID: 29383115 PMCID: PMC5777727 DOI: 10.18632/oncotarget.21773

Abstract

Glioma cells release exosomes in culture and into the extracellular matrix

Keywords: exosome; glial fibrillary acidic protein; glioblastoma; survivin; vaccine

Conflict of interest statement

CONFLICTS OF INTEREST R.A. Fenstermaker and M.J. Ciesielski are co-inventors listed on patents regarding the survivin vaccine and are co-founders of MimiVax, LLC, which has licensed such patents from

References

  1. Oncotarget. 2015 Sep 29;6(29):26971-81 - PubMed
  2. Mol Biol Cell. 2006 Mar;17(3):1483-93 - PubMed
  3. Apoptosis. 2011 Jan;16(1):1-12 - PubMed
  4. Hum Vaccin Immunother. 2014;10(11):3201-13 - PubMed
  5. J Neurosci. 2015 Jan 14;35(2):518-26 - PubMed
  6. Oncoimmunology. 2015 May 7;4(8):e1026529 - PubMed
  7. Front Immunol. 2014 Sep 16;5:442 - PubMed
  8. Oncotarget. 2017 Jan 3;8(1):1416-1428 - PubMed
  9. Mol Neurobiol. 2015 ;51(3):1462-7 - PubMed
  10. J Surg Oncol. 1989 May;41(1):22-6 - PubMed
  11. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7 - PubMed
  12. J Extracell Vesicles. 2013 Mar 05;2:null - PubMed
  13. Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22 - PubMed
  14. Cancer Immunol Immunother. 2010 Aug;59(8):1211-21 - PubMed
  15. J Neurooncol. 2005 May;72(3):231-8 - PubMed
  16. Cancer Immunol Immunother. 2012 Nov;61(11):2091-103 - PubMed
  17. J Neurooncol. 2016 Apr;127(2):391-400 - PubMed
  18. Am J Pathol. 2008 Aug;173(2):575-85 - PubMed
  19. Acta Pharm Sin B. 2016 Jul;6(4):287-96 - PubMed
  20. PLoS One. 2012;7(10):e46737 - PubMed
  21. Cell Rep. 2013 Dec 12;5(5):1159-68 - PubMed
  22. Clin Cancer Res. 2008 Aug 15;14(16):5000-5 - PubMed
  23. J Clin Neurosci. 2017 Jan;35:13-23 - PubMed
  24. J Cell Biol. 1991 Mar;112(6):1205-13 - PubMed
  25. Neuro Oncol. 2014 Apr;16(4):520-7 - PubMed
  26. Cancer Res. 2008 Jul 15;68(14 ):5778-84 - PubMed
  27. J Clin Oncol. 2002 Feb 15;20(4):1063-8 - PubMed
  28. Oncotarget. 2016 Jan 5;7(1):593-609 - PubMed
  29. Am J Pathol. 1998 Jan;152(1):43-9 - PubMed
  30. Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15100-5 - PubMed
  31. Nature. 1998 Dec 10;396(6711):580-4 - PubMed
  32. Cancer Immunol Immunother. 2016 Nov;65(11):1339-1352 - PubMed
  33. Neuron. 1996 Oct;17(4):607-15 - PubMed
  34. EMBO J. 2003 Jun 2;22(11):2729-40 - PubMed
  35. Anat Rec. 1988 Mar;220(3):296-9 - PubMed
  36. Nat Protoc. 2012 Jun 14;7(7):1311-26 - PubMed
  37. Cancer. 2003 Feb 15;97(4):1077-83 - PubMed
  38. J Neuropathol Exp Neurol. 2001 May;60(5):449-61 - PubMed
  39. Int J Oncol. 2007 Jan;30(1):123-8 - PubMed
  40. Neuromolecular Med. 2014 Sep;16(3):565-77 - PubMed
  41. Stroke. 2000 Nov;31(11):2670-7 - PubMed
  42. Biol Cell. 1998 Jan;90(1):53-61 - PubMed
  43. FASEB J. 2009 May;23(5):1541-57 - PubMed
  44. Nat Cell Biol. 2008 Dec;10(12):1470-6 - PubMed
  45. Brain. 2007 Dec;130(Pt 12):3336-41 - PubMed
  46. Oncoimmunology. 2015 Mar 2;4(6):e1008347 - PubMed
  47. Acta Neurol Scand. 2007 Dec;116(6):380-4 - PubMed
  48. J Neuroimmunol. 1991 Dec;35(1-3):119-29 - PubMed
  49. Expert Rev Mol Diagn. 2014 Sep;14(7):819-25 - PubMed
  50. Sci Rep. 2014 Jun 10;4:5237 - PubMed
  51. Crit Care. 2015 Oct 12;19:362 - PubMed
  52. Cancer Res. 2001 Aug 15;61(16):5964-8 - PubMed
  53. Transl Oncol. 2014 Dec;7(6):752-8 - PubMed

Publication Types

Grant support